Utama › Hidradenitis Suppurativa › Illinois
Kajian klinikal Hidradenitis Suppurativa di Illinois
6 kajian untuk Hidradenitis Suppurativa sedang mencari peserta di lokasi di Illinois.
Bandar di Illinois
Teks kajian rasmi (Bahasa Inggeris)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Endeavor Health, Glenview
- Dundee Dermatology, West Dundee
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Chicago
Mengambil pesertaFasa 2
Umur 18 hingga 79 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07783542A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- NorthShore University Health System - Endeavor Health Medical Group - Skokie - Woods Drive- Site Number : 8400019, Skokie
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07225569Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US125, Chicago
- Investigative Site US093, Chicago
- Investigative Site US039, West Dundee
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06855498Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Endeavor Health Medical Group, Skokie
Mengambil pesertaFasa 2
Umur 12 hingga 17 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07213973A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- Northwestern University, Chicago
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 71 · Semua jantina · Dikemas kini 16 Apr 2026 · NCT07123038Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.